Wie können wir helfen?
Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study
You do not have access to this post.
1445534
{:YQSWFA7Q}
1
https://www.zotero.org/styles/urban-research-and-practice?source=1
50
default
1
1
149
http://www.hautkrebs-leitlinien.de/wp-content/plugins/zotpress/